Table 3.
Observed values of responses for 15 formulations of pomegranate extract solid lipid nanoparticles
| Formulation code | Observed responses (Y1 to Y5)
|
||||
|---|---|---|---|---|---|
| Particle size* (nm) | PDI* | Zeta potential* (mV) | Entrapment efficiency* (%) | Cumulative release* (%) | |
| F1 | 427.9±9.2 | 0.49±0.081 | −34.4±2.8 | 60.26±1.9 | 68.14±3.0 |
| F2 | 623.3±11.3 | 0.50±0.067 | −29.8±2.1 | 56.02±2.6 | 75.53±3.9 |
| F3 | 548.9±15.3 | 0.48±0.021 | −40.4±3.8 | 65.23±3.2 | 60.36±2.9 |
| F4 | 499.3±7.5 | 0.52±0.045 | −30.4±2.7 | 61.89±4.1 | 62.35±3.8 |
| F5 | 407.5±6.3 | 0.60±0.025 | −45.5±1.5 | 58.96±2.2 | 70.48±2.7 |
| F6 | 610.3±8.4 | 0.54±0.071 | −32.5±3.1 | 63.85±3.4 | 64.10±3.5 |
| F7 | 625.3±14.4 | 0.58±0.036 | −32.5±4.1 | 62.56±3.9 | 66.35±2.8 |
| F8 | 456.6±15.6 | 0.56±0.018 | −33.0±1.6 | 61.38±2.4 | 66.71±3.1 |
| F9 | 651.9±6.9 | 0.37±0.059 | −32.1±3.3 | 58.26±3.8 | 73.28±2.6 |
| F10 | 567.5±10.9 | 0.46±0.081 | −33.1±2.2 | 59.92±2.7 | 66.47±3.4 |
| F11 | 579.1±17.1 | 0.42±0.014 | −36.7±4.3 | 62.19±1.8 | 62.22±1.9 |
| F12 | 599.1±8.7 | 0.34±0.026 | −36.4±3.4 | 61.24±2.5 | 66.56±3.6 |
| F13 | 504.6±12.5 | 0.41±0.037 | −31.5±2.6 | 60.15±3.6 | 64.88±2.4 |
| F14 | 525.9±14.6 | 0.32±0.098 | −30.4±3.2 | 61.54±4.2 | 67.20±3.2 |
| F15 | 473.7±16.9 | 0.38±0.076 | −33.0±2.8 | 59.33±1.6 | 66.63±4.1 |
Note:
*
Results are expressed as the mean of three replicates ± SD.
Abbreviation: PDI, polydispersity index.